Abstract
Tic related disorders affect 4–20% of the population, mostly idiopathic, can be grouped in a wide spectrum of severity, where the most severe end is Tourette Syndrome (TS). Tics are arrhythmic hyperkinesias to whom execution the subject is forced by a “premonitory urge” that can be classified as sensory tic, just-right experience or urge without obsession. If an intact volitional inhibition allows patients to temporarily suppress tics, a lack or deficit in automatic inhibition is involved in the genesis of the disorder. Studies have assessed the presence of intrinsic microscopic and macroscopic anomalies in striatal circuits and relative cortical areas in association with a hyperdopaminergic state in the basal forebrain. Prepulse inhibition (PPI) of the startle reflex is a measure of inhibitory functions by which a weak sensory stimulus inhibits the elicitation of a startle response determined by a sudden intense stimulus. It is considered an operation measure of sensorimotor gating, a neural process by which unnecessary stimuli are eliminated from awareness. Evidence points out that the limbic domain of the CSTC loops, dopamine and GABA receptors within the striatum play an important role in PPI modulation. It is conceivable that a sensorimotor gating deficit may be involved in the genesis of premonitory urge and symptoms. Therefore, correcting the sensorimotor gating deficit may be considered a target for tic-related disorders therapies; in such case PPI (as well as other indirect estimators of sensorimotor gating) could represent therapeutic impact predictors.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
TIC-related disorders and Tourette Syndrome
Tic disorders affect 4–20% of the population [1]. Most cases are classified as idiopathic; they can be grouped in a wide spectrum of severity, where the most severe end is represented by Tourette Syndrome (TS) that has a lifetime prevalence of 0.5–0.7% [2]. Tics are arrhythmic hyperkinesias, described as sudden, rapid movements or vocalizations, characterized by a different grade of complexity (in terms of number of muscular groups involved), and enhanced by emotive factors and fatigue [3]. They are typically stereotyped, fluctuating, distractible and suggestible [4].
The onset of TS is typically in childhood (the majority between the ages of 4–6 years). Tic severity typically peaks in adolescence (the majority between the ages of 10–12 years). In most cases, symptoms are fluctuating, following a waxing and waning course. Even if they have a fluctuating course, from the onset to the peak of the disease the symptoms tend to aggravate. The most common tics at onset are simple motor tics [5]. The appearance of additional tics typically progresses in a rostral-caudal pattern, involving trunk and limbs, with a simultaneous increase of the number of muscular groups involved. Vocal tics tend to manifest only in advanced states of the disease [6].
Most cases will show an improvement of symptoms by late adolescence or early adulthood [7]. If in less than 1/3 of individuals there will be a complete remission of symptoms, the remainder will have mild, often barely noticeable symptoms, except for a 10–20% of cases that will continue to have significant symptoms [8].
All idiopathic tic-related disorders show an association with psychiatric disorders. This is particularly true for TS. Only approximately 20% of TS cases occur in absence of a significant comorbid diagnosis [9]. The most represented comorbidities are obsessive–compulsive disorder (OCD), and attention deficit-hyperactivity disorder (ADHD), which occur in 60% of individuals [10]. Less common, but still more frequent than in the general population are autism spectrum disorders, depression, anxiety and behavioural disorders [10].
Tics are generally considered movements to whom execution the subject is forced by a “premonitory urge” [6]: sensation of discomfort that tic emission helps to alleviate or discharge. Premonitory urges can be classified as sensory tic, just-right experiences or urges (without obsessions) [11].
Sensory tic is a bodily sensation, mainly musculoskeletal, perceived as uncomfortable. A just-right experience is an inner discomfort produced by perception that elements of the surrounding environment (sounds, objects, people, movements, actions) are not harmonized in a certain “right way.” This experience has been compared to a compulsion [12], even if is more closely related, by a biological point of view, to tic-related disorders than to OCDs [13]. An urge without obsession is a drive to do a certain action associated with neither sensory phenomena nor a sense of disharmony of the surrounding environment.
CSTC loops abnormalities in tic-related disorders
The limbic, associative and sensorimotor domain of cortico-striatal-thalamo-cortical (CSTC) loops are composed of multiple largely parallel (but partially overlapping) circuits that direct information from cerebral cortex to basal ganglia and thalamus, and then back again to specific region of the cortex (Fig. 1). Dopamine is a crucial regulator of striatal microcircuitries. Dopaminergic neurons in the ventral tegmental area (VTA) preferentially innervate the nucleus accumbens, while dopaminergic neurons in the substantia nigra mainly project to the dorsal striatum [14].
Double-blind clinical trials in which neuroleptics, that preferentially block dopaminergic D2 receptors (such as haloperidol and pimozide), have been found to be effective in the temporary suppression of tics [15], as well as data from animal models, in which the administration of tetrabenazine (inhibitor of the uptake of DA into synaptic vesicles) resulted effective in tic suppression [16], have posed the basis for a “dopamine hypothesis”: tic disorders can be related with an excess of nigrostriatal dopaminergic activity. This hypothesis is supported by in vivo neuroimaging studies that documented increase of dopamine transporter (DAT) binding in the neostriatum and increase of DA storage and DA release in the ventral striatum [17].
Most neurons (> 90%) in the striatum are γ-aminobutyric acid-ergic (GABAergic) medium spiny neurons (MSNs). They are activated by motor behaviours elicited by memory-encoded or environmental cues, exhibiting a context-dependant firing pattern [18]. Whitin the striatum MSNs form a weak lateral inhibitory network (feedback inhibition), important in regulating striatal output, while GABAergic interneurons, despite in much smaller numbers, exert a powerful control over striatal excitability (feedforward inhibition), modulating MSNs excitability. Feedforward inhibition is mediated by fast-spiking GABAergic interneurons (FSINs) [19]. FSINs receive direct cortical inputs predominantly from lateral cortical regions, including the primary motor and somatosensory cortex. These interneurons interact with adjacent MSNs. It does appear that FSINs are activated in a coordinated fashion just prior to a decision being made in a striatal-dependent task [20]; once activated, they determine a synchronous inhibition of many adjacent MSNs via synapses on cell bodies and proximal dendrites. A second class of GABAergic interneurons comprises the neuropeptide Y (NPY), nitric oxide synthetase and somatostatin expressing interneurons. These cells present a least dense axonal arborization and electrophysiologically characterized by low threshold calcium spikes [21].
Dopaminergic afferences exert an influence also on GABAergic interneurons activity via presynaptic and postsynaptic actions. Dopamine release induced by drugs (such as methamphetamine) increases the activity, while dopamine D2 receptor antagonist depresses the firing frequency of FSINs. FSINs activity is enhanced directly by postsynaptic D5 receptors and indirectly by reducing GABAergic inputs to FSINs via presynaptic D2 receptors [22, 23]. Inhibition of the nigrostriatal circuit causes impaired and poorly timed synchronization of FSINs activity [24]. On the other hand, repeated administration of methamphetamine enhances preproNPY mRNA expression in a D1-dependent manner. Low threshold interneurons are depolarized by dopamine throughout D1 receptors [25]. While dopamine depletion promotes an oscillatory activity in FSINs, a dopaminergic excess promotes a tonic activity, both conditions may impair MSN activity and consequentially corticostriatal encoding [26]. Furthermore, it has been showed that endogenous dopamine influences striatal microcircuitries by negative regulating the number of tyrosine-hydroxylase (TH) expressing MSNs, whom TH immunoreactive axons interact with proximal dendrites and soma of NPY expressing interneurons [27].
FSINs have been widely implicated in studies regarding reward-seeking since activation of FSINs have been showed to result in behavioural changes to reward. One study, manipulating neuronal firing of FSINs and assessing throughout microdialysis the changes in GABA and glutamate levels, showed that FSINs activity influences the initial expression of reward conditioned responses, and that their influence on MSNs declines with training. Moreover, FSINs activity can mediate learning by enhancing performance during associative learning [28].
The striatum also presents cholinergic tonically active neurons (TANs). Both TANs and dopaminergic neurons emit robust signals following reward-related events, signals involved in the calculation of perceived salience of numerous perceptual cues arriving to the striatum. It has been postulated that dopamine (DA) and acetylcholine (ACh) act antagonistically in the striatum, having opposing effects on the excitability of MSNs [29]. Both striatal DA and ACh affect plasticity of cortico-striatal transmission, therefore they are both crucial in learning processes [30].
In monkeys performing probabilistic instrumental conditioning tasks, although different events yielded responses with different latencies, the response of the two populations coincided, indicating integration at the target level, yet while the DA neurons’ response reflects mismatch between expectation and outcome, TANs activity is invariant to reward predictability. Therefore, is likely that striatal cholinergic and dopaminergic systems carry distinct messages by different means, which can be integrated differently to shape the basal ganglia response to reward-related events [31].
Not only dopaminergic and cholinergic afferences act antagonistically on MSNs, but also dopamine modulates the activity of TANs: stimulation of dopaminergic axons in dorsal striatum modifies ionic conductance in TANs, suggesting that dopamine dynamically controls cholinergic tone. Reciprocally, TANs interneurons modulate dopamine output thought activation of both muscarinic and nicotinic cholinergic receptors on dopamine terminals [32].
Neuropathology studies of post-mortem TS brains documented a greater than 50% reduction in the FSINs population in the caudate nucleus and a 30–40% reduction of these same cells in the putamen [33]. A more recent post-mortem study confirmed a 50–60% decrease of both FSINs as well as a loss of TANs in the caudate nucleus and putamen; in addition, TANs were decreased in TS patients in the associative and sensorimotor regions, but not in the limbic regions of the striatum, such that the normal gradient in density of cholinergic cells (highest in associative regions, intermediate in sensorimotor and lowest in limbic regions) was abolished [34].
The complex interaction of motor and psychiatric symptoms and evidence from neuroimaging indicate that tic-related disorder pathophysiology involves CSTC networks that span different functions, including sensorimotor, limbic and associative networks.
Volumetric magnetic resonance imaging (MRI) studies showed an approximate 5% reduction in caudate volume in TS patients [33], data that fits the microscopical loss of interneurons. It was also found an inverse correlation between caudate volume in childhood and tic severity in adulthood [35]. Cortical thickness has also been measured comparing TS-affected children/adolescents with age- and sex-matched healthy controls, showing a cortical thinning most evident in the regions of the sensory and motor cortex. Thinning in these regions directly correlated with tic severity [36]. Cortical thinning was also found in other regions, including lateral orbitofrontal and dorsolateral cortex. This data could correlate with an increased vulnerability to psychiatric comorbidities, such as OCD.
In one study, using functional magnetic resonance (fMRI), the spatiotemporal pattern of coactivation of areas within the motor cortex during tics was contrasted with that seen in healthy control subjects during matched, intentional movements. The supplementary motor area (SMA) showed a significant broader profile of cross-correlation to the motor cortex during tic rather than intentional movements, highlighting a potential importance of the SMA hyperactivity in tic generation [37]. In another study, tic behaviour was highly correlated with an increased activity in a set of areas, including not only SMA but also premotor, anterior cingulate, dorsolateral-rostral prefrontal, primary motor cortices, Broca’s area, insula, claustrum. Additionally, a fluorodeoxyglucose (FDG)-PET study reported differences within the connectivity within these areas and the basal ganglia (especially the ventral striatum) [38]. By distinguishing a frontoparietal network (likely involved in rapid and adaptative control of movements) and a cingulo-opercular network (apparently significant for set maintenance), it was found that adolescents with TS had immature patterns of connectivity, particularly within the frontoparietal network; additionally, aberrant connections were also documented in brain regions of the frontoparietal network [39].
Deep brain stimulation (DBS) of centromedial thalamus and globus pallidus pars interna (GPi) have been tested in some randomized controlled trials (RCTs) of small cohorts of TS patients. Some of these RCTs reported a significant and long-term reduction of tic during active DBS compared to shame [40,41,42]. However, DBS outcomes vary substantially across patients and reliable predictors of therapeutic responses have not been identified yet [43]. Studies reported that a structural connectivity of the site of stimulation in centromedial thalamus and GPi to the specific components of the frontostriatal, limbic and motor networks were correlated with tic improvement, thus suggesting that the connectivity profile of the stimulation site may be related to clinical outcomes of DBS in tic-related disorders [44,45,46]. According to these previous studies, Johnson et al. [47], using tractography maps, showed that DBS of the GPi may be associated with tic improvement following modulation of limbic, associative networks and the efficiency was also correlated with a higher connectivity to caudate, thalamus and cerebellum, while modulation of sensorimotor and parieto-temporal-occipital networks and a higher connectivity to putamen and cerebellum may be responsible of tic improvement following DBS of the centromedial thalamus. According to the authors, the stimulation of GPi may improve tics by decreasing activity in downstream limbic and associative tic-related networks, while stimulation of centromedial thalamus may improve tics by directly disrupting local tic-related pathological activity.
McCairn et al. [48], after obtaining a pharmacologic motor tic animal model by microinjecting a GABA-antagonist within the sensorimotor striatum: putamen, proposed the hypothesis that tics are generated by a dynamical process that involves an abnormal reciprocal interaction between cortex and basal ganglia, in which an abnormal dopamine burst represents a necessary condition for motor tic production. It is conceivable that an abnormal dopamine efflux alters the typical selection processes implemented by the CSTCs loops of selecting intrinsic noise and inputs received by the system from cortical regions, making it overly sensitive to the received signals so that spurious primary cortex activations result to be disinhibited.
In patients treated with DBS, both GPi and centromedial thalamus stimulation capacity to reduce tics were correlated with a higher connectivity of the stimulated areas to cerebellum, suggesting the presence of an aberrant cerebellar cortex activity during tic production through dysinaptic link connecting the basal ganglia to the cerebellum [49]. These links are dysinaptic since it has been described the interposition of pontine nuclei between the subthalamic nucleus and the cerebellar nuclei, and excitatory since most of the pontine neurons projecting to the cerebellum are glutamatergic. Once activated, the cerebellum might feedback the basal ganglia and directly affect the descending motor pathways [50]. The augmented activity of the cerebellum may determine a further increase of the sensitivity of the selection process within the basal ganglia-thalamo-cortical system and spurious activations of primary motor cortex may be selected more easily and develop into motor tics. Further studies are needed to prove this hypothesis and to prove an effective role of an abnormal cerebellar activity in tic production.
In the genesis of the abovedescribed anomalies within the CSTCs loops may be involved neuroinflammatory processes. Lennington et al. [51] compared basal ganglia transcriptome by RNA sequencing in the caudate and putamen of 9 TS with 9 matched normal confronts, finding 309 down-regulated and 822 upregulated genes in TS individuals. The 9 TS patients did not meet criteria for Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infection (PANDAS) or Pediatric Acute onset Neuropsychiatric Syndrome (PANS). However, in addition to expected evidence of metabolic alterations of striatal interneurons (FSINs and TANs) that may be linked to their death and dysfunction, they found a significant increase in immune and inflammatory transcripts that appear to be endogenous to the CNS. It remains unclear whether the interneurons death is secondary to neuroinflammation or neuroinflammation is caused by the interneuron’s death. An association of symptoms onset or exacerbation of tic disorders with acute infections has been documented [52]. Further studies are necessary to redeem the exact role of neuroinflammation in tic-related disorders.
Prepulse inhibition
Prepulse inhibition (PPI) of the startle reflex is a measure of inhibitory functions by which a weak sensory stimulus (prepulse) inhibits the elicitation of a startle response caused by a sudden intense stimulus (pulse). It is viewed as an operational measure of a neural process called “sensorimotor gating” by which unnecessary stimuli are eliminated (or “gated out”) from awareness, so that an individual can focus attention on the most salient aspects of the surrounding environment [53].
The startle reflex consists of a contraction of skeletal and facial muscles in response to a sudden intense stimulus that may be presented by across multiple modalities (visual, auditory or tactile). PPI is the normal suppression of the startle reflex that occurs when the intense startling stimulus is preceded by a relatively weak stimulus. In order to inhibit startle, the prepulse must precede the pulse by 30–500 ms [54]. The major advantage of the PPI of the startle reflex is that it can be studied across species, leading to translational research opportunities [53, 55, 56]. In humans, it is possible to evaluate the eyeblink component of the startle by using electromyography (EMG) of the orbicularis oculi muscle; in rats and mice, Stabilimeter Chamber measures the whole-body flinch elicited by stimuli that are similar (or identical) to those used in humans [54] (Fig. 2).
Different theories about how information is processed have been formulated. One first theory affirmed that incident stimuli are processed in a sequential manner through a series of “stages” that occur at progressively higher sites in the central nervous system. Abnormalities of this process were conceptualized as potentially occurring at various stages resulting in a heterogenous spectrum of cognitive deficiencies and associated behaviours. For example, according to this theory, psychotic symptoms were viewed as a result of a deficit in early stages of information processing. Such deficit was thought to cause a cascade of unnecessary information at downstream stages that ultimately resulted in an abnormal cognitive integration [53].
The “stages” model has been increasingly challenged by an “integrationist” model that relies on neural networks theory: the processing of incident stimuli is operated not only by a filter action within the progressively higher sensitive sites but also by the integration of a time-coordinated activity of neurons in multiple sites at different levels of the nervous system [57].
This integrated, multisite activity is thought to be fundamental for the “sensorimotor gating,” a neural process intended to help the organism regulating environmental inputs in order to allocate attentional resources to salient stimuli [58]. The specific characteristic of an individual’s gating process is thought as being plastic and influenced by a combination of genetic traits [59] and environmental factors such as neonatal insult [60] and social isolation [61] as well as toxic influences of neurochemical and hormonal milieu of the nervous system [62].
Studies have proved a PPI disruption in several psychiatric disorders. PPI has been particularly valuable for studying the neurobiology of schizophrenia and related spectrum disorders since gating deficit is an important feature of pathophysiology of the disease and deficits in gating of cognitive and sensory information are particularly relevant clinical features of the disorder [59].
Different data suggest that CTSC loops are involved in the modulation of PPI: a loss of healthy neural communication between limbic and basal ganglia structures results in PPI deficits, underlining the existence of cortico-striato-pallido-pontine (CSPP) circuits [63]. Manipulations of the hippocampus and basolateral amygdala, as well as dysfunctions in the medial prefrontal cortex and the orbitofrontal cortex, can lead to changes in PPI. While it was originally thought that the hippocampus acts on PPI modulation via the nucleus accumbens, recent anatomical and functional data suggest that the efferent connections responsible for PPI disruption are directed from hippocampus to medial prefrontal cortex [64].
There is also evidence pointing out that dopamine receptors within the striatum nucleus plays out an important role in PPI modulation: in preclinical studies, the activation of dopamine receptors by either direct agonist (such as apomorphine) and indirect agonist (such as amphetamine) leads to robust deficit of PPI [55]. In human, volunteers were tested PPI after administration of the D2 receptor antagonist (and probable D1 receptor partial agonist) bromocriptine (1.25 mg), the receptor antagonist haloperidol (3 mg), and a combined treatment with the cited doses of the two drugs in a balanced double-blind protocol. In all cases, the tested prepulse-to-pulse interval was 120 ms. The baseline startle response was not altered by any of the pharmacological treatments and PPI was observed to be appropriately dependent upon the prepulse intensity. In all conditions, bromocriptine robustly reduced PPI. However, somewhat paradoxically, the dopamine antagonist haloperidol also elicited a much smaller, albeit statistically significant, decrement in PPI [65]. A second study by the same group confirmed similar findings about bromocriptine effect on PPI but failed to replicate the effect of haloperidol [66]. Therefore, the haloperidol effect on PPI seems not to be reliable in humans. However, the most significant data that emerged in these two studies was that haloperidol is effective in antagonizing the PPI-disruptive effect of bromocriptine. The same result was also found in animals in another study [55]. Moreover, evidence suggests that GABAergic system participate in determining PPI. Using magnetoencephalography, Inui et al. [67] evaluated the inhibition on acoustic startle determined by weak stimuli presented at 10–800 ms before the startle, showing the existence of two distinct inhibition peaking at approximately 20–60 ms and 600 ms that appear to reflect inhibitory post-synaptic potentials (IPSPs) of FSINs and cortical somatostatin-positive interneurons (Martinotti cells). In another study [68], the inhibition occurring at 20–60 ms has been furtherly divided in two components, since the administration of diazepam enhances the inhibition at 10–20 ms, while the administration of baclofen enhances the inhibition at 40–50 ms. The fact that the short-latency component is elicited by diazepam suggests the involvement of GABAA receptors, while the effect of the baclofen on the further component suggests the involvement of GABAB receptors.
Prepulse inhibition in tic-related disorders
Tics can be transiently suppressed by volitional effort or will. This concept has led to the hypothesis that tics result from a failure of motor systems’ tonic inhibition mechanisms. It has also been hypothesized a deficit in mechanism of automatic inhibition [69]. The brain is subjected to a continuous flow from the external environment of potential triggers to specifical movements. These potential movements are automatically suppressed by a process non subjected to voluntary control [70].
In one study [71], volitional inhibition was evaluated by conditional stop signal task (CSST) and automatic inhibition by using the masked priming task (how the reaction time to imperative stimulus is affected by the presence of an unperceived priming cue), excluding deficits in the volitional inhibition and outlining an altered automatic inhibition. This study suggests that intact volitional inhibition allows patients to voluntarily suppress their tics, while a lack or deficit in automatic inhibition is involved in the genesis of the tic disorder. PPI is an operational measure of sensorimotor gating, a process of central inhibition of unnecessary incident stimuli. It can be considered an automatic process, apart from a volitional component correlated with sensitive attention. At the same time, a lack or deficit in automatic inhibition is involved in the genesis of tic-related disorders. Thus, it is conceivable that the pathological process responsible for the loss of sensorimotor gating in tic disorders may determine the genesis of the premonitory urge and symptoms.
Studies showed that TS patients exhibit a blunted PPI. In a first study, utilizing supraorbital electrical nerve stimulation to produce adequate blink responses and measuring the decrease in amplitude resulting from electric prestimuli just above sensory threshold, 7 boys comorbid for ADHD and tic disorder had significantly reduced PPI compared to 14 screened controls and seven boys with ADHD alone [72]. A second study applied a “fMRI friendly” protocol to detect PPI in TS children: bilateral eyeblink PPI was tested using chin air puffs to elicit startle and prepuffs to the dorsal hand surface as inhibiting stimuli; compared to control subjects, TS children exhibited comparable startle magnitude and habituation, but significantly reduced PPI after prepuffs [56]. Following a similar protocol to evaluate PPI inhibition, in another study, whole-brain fMRI was taken in 17 TS adults and 16 healthy controls in order to evaluate the neural correlates of PPI in adult TS subjects. A normal level of PPI in healthy controls and a considerably lower in TS patients were observed, even if the difference did not reach statistical significance. In healthy subjects, PPI was associated with increased activity in multiple brain regions and group comparison identified 9 regions where brain activity during PPI differed significantly between TS and healthy controls; among these 9 regions, regression analysis demonstrated a significant positive linear relationship between the current tic severity (measured by Yale Global Tic Severity Scale) and the activation of left caudate (while the right caudate only approached statistical significance) [73]. This study supports the abovementioned role of an abnormal caudate nucleus functioning in the development of tic disorders and suggests that such functioning could alter sensorimotor gating mechanisms.
PPI is not the only means of investigating sensorimotor gating. Another mean is assessing sensorimotor gating by event-related potentials (ERPs) paradigms utilizing paired stimuli to test habituation, strategy that grants a remarkable temporal precision. Such type of studies has consistently identified a diminished amplitude of the contingent negative variation (CNV) component, which can be considered as a marker of cognitive anticipation for a forthcoming sensory event, in both adults and children affected by TS [74]. Additionally, patients with more severe tics have lower CNV amplitudes, indicating a reduced pre-conscious capacity to anticipate environmental stimuli [75].
There is also a report affirming that TS patients endorse difficulties in sensory gating processes, specifically the ability to modulate stimulus intensity preventing perceptual inundation and the ability to focus attention or prevent distractibility. It was also assessed a low threshold of perception causing over-inclusion and distractibility, a vulnerability to perceptual and attentional anomalies during periods of fatigue and stress [76]. Another work reported complementary findings but also reported a heightened sensitivity to sensory stimulation in 80% of the tested TS patients that was not accompanied by significant differences of tactile and olfactory thresholds compared to control subjects. The authors concluded that subjective sensitivity differences in TS patients reflected altered central information processing rather than enhanced peripheral sensory detection [77].
Turning to internal stimuli, it remains uncertain whether TS sensory gating dysfunction affects interoceptive stimuli. In one study among 12 adult TS subjects (without psychiatric comorbidities) and 12 healthy controls, magnetoencephalography was used to study volitional finger movement in two task conditions: a self-paced and an externally triggered task. If motor field amplitudes did not differ between the two groups, in both tasks, motor field peak amplitudes were increased in TS patients. Moreover, larger motor evoked field amplitudes during self-paced movements were inversely correlated with motor tic frequency and severity, suggesting the presence of an overflow of interoceptive stimuli determined by an altered subcortical gating [78]. Further experiments are needed to confirm this interpretation.
Tic therapies and prepulse inhibition
As mentioned, effective sites for DBS in TS patients are GPi and centromedial thalamus. One study demonstrated that high frequency DBS of the thalamic centromedian parafascicular nucleus and of the entopeduncular nucleus (EPN) in mice (EPN can be considered a rodent analog of the human GPi) prevented the PPI disruptive effects of apomorphine, a dopaminergic agonist [79]. However, the effect of DBS on PPI in humans has not been proved yet. In a recent study, PPI acoustic startle reflex was measured in TS patients, treated with DBS of the centromedian and ventro-oral internal thalamic nucleus and the anterior limb of internal capsule-nucleus accumbens area respectively, and aged-/gender-matched healthy controls. PPI of the DBS groups was measured in randomized order in ON and OFF stimulation condition. No significant differences were found in PPI (%) of patients with TS between ON and OFF condition. However, if PPI levels were significantly reduced in TS patients in the ON condition compared to heathy controls, no significant difference was found in PPI between TS in the OFF condition compared to healthy controls [80].
Among all of TS therapeutics to date, Habit Reversal Therapy, also termed as Comprehensive Behavioural Interventions for Tics (CBIT), has been proved to have a comparable, if not better, efficacy to other known tic medications in both TS patients [81]. CBIT relates heavily on the ability to initiate an appropriate preventative response after detecting the premonitory urge. This process is very similar to that used in cognitive and behavioural therapy (CBT) where individuals identify an event (such as a delusion, obsession) and initiate a cognitive and behavioural process in order to interrupt the consequences of the event (such as avoidance, compulsion). The purpose is to render over time the volitional components of this inhibitory process more automatic, in other words to shift the regulation of this process from cortical to subcortical circuitries. CBT is used in schizophrenia, where PPI disruption has been assessed as a predictor of the therapeutic impact of CBT [82]. Therefore, it is possible to assert that PPI could represent a therapeutic impact predictor also in CBIT in tic-related disorders.
Finally, the sensorimotor gating intrinsic to tic-related disorders suggests the possibility of an enhancement of the CBIT approach by administration of “pro-cognitive therapies” [83] for augmenting sensorimotor gating processes that would potentiate the ability to assert volitional control over semiautomatic motor response. It has been proved that, especially in individuals with low levels of PPI, different drugs can enhance PPI, such as atypical antipsychotics, the cathechol-O-methyl-transferase inhibitors, tolcapone, the low potency NMDA antagonist, memantine.
After a study showed that 5alpha-reductase inhibitor finasteride could reduce tic severity in 10 adult TS male patients [84], PPI was utilized to explicate such result: in rats finasteride could reduce the PPI disruptive effect of dopaminergic agonists after systemic, intraventricular and intracerebral administration. However, the administration of the same drug in other brain regions failed to replicate the same result, thus suggesting that the finasteride effect on PPI reflects the action on the cells of the ventral striatum [85]. This study suggested that PPI may be considered as an effective marker to test the effectiveness of treatment in tic-related disorders.
Using a D1CT-7 mice, a well-characterised animal model of TS, it has been proven that acute environmental stress is capable to exacerbate tic-like responses and cause sensorimotor gating deficits (measured by PPI). These phenomena were associated with an increase in plasma corticosterone as well as cortical neurosteroids, such as allopregnanolone. The effects of allopregnanolone on the GABA-A receptors are antagonized by its 3beta-epimer, isoallopregnanolone [86]. In a recent study the administration of isoallopregnanolone in D1CT-7 mice not only produced a significant reduction in tic-like behaviours but also significantly reversed the PPI disruptive effect produced by stress [87]. Given recent evidence that positive allosteric modulators of GABA-A receptors containing alpha6 subunities oppose the behavioural effects of dopamine, in D1CT-7 mice was also tested of DK-I-56–1, a highly selective positive allosteric modulator of GABA-A receptors containing alpha6-subunities. DK-I-56–1 significantly reduced tic-like behaviours and PPI deficit in the transgenic mice; DK-I-56–1 also prevented the exacerbation of spontaneous eyeblink reflex induced by potent dopamine D1 receptor antagonist SKF 82,958, a proxy for tic-like responses [88].
Conclusions
The precise pathophysiologic mechanism of tic-related disorders remains unclear, but a CSTCs circuit dysfunction is likely to be involved. It has been documented a significant reduction in interneuronal population in the striatum associated with an aberrant neurotransmitter functioning, including dopamine and GABA. Such features on a microscopic scale coexist on a macroscopic scale with network abnormalities within CSTCs loops documented by volumetric and functional MRI studies, PET studies and studies that associated DBS with tractography maps. The dysfunction of striatal interneurons and the network abnormalities observed within the CSTCs loops may be considered candidate mechanistic link in tic-related disorder pathophysiology.
Tic-related disorders may be also characterized by a sensorimotor gating deficit, which may be determined by the described anomalies within the CSTC loops. Sensorimotor gating is the suppression of irrelevant information to ensure the ability to focus on relevant stimuli; it can be measured using prepulse inhibition (PPI) of the startle reflex. If sensorimotor gating is truly impaired in tic-related disorders, PPI and others indirect indicators of sensorimotor gating may become a marker to test the effectiveness of actual and future treatments.
Notably, a GABAergic interneurons dysfunction is postulated to underlie several neurodevelopmental disorders, including OCD, autism and schizophrenia, all of which exhibit impaired sensorimotor gating [89]. Further research is needed to (1) assess the effective presence of a sensorimotor gating deficit in tic-related disorders, preferentially in studies made in human subjects, (2) elucidate the effective pathophysiological role of GABAergic interneurons and altered network connectivity in determining a deficit in sensorimotor gating processes and (3) evaluate the effectiveness of indirect markers of sensorimotor gating process, such as PPI, as indicators to test treatment effectiveness in tic-related disorders.
References
Cubo E (2012) Review of prevalence studies of tic disorders: methodological caveats. Tremor Other Hyperkinetic Mov (N Y). 2:tre-02-61-349-1. https://doi.org/10.7916/D8445K68
Scahill L, Dalsgaard S, Bradbury K (2013) The prevalence of Tourette syndrome and its relationship to clinical features. In: Martino D, Leckman JF (ed) Tourette Syndrome. Oxford University Press, Oxford. https://doi.org/10.1093/med/9780199796267.003.0006
Lin H, Katsovich L, Ghebremichael M, Findley DB, Grantz H, Lombroso PJ, King RA, Zhang H, Leckman JF (2007) Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 48(2):157–166. https://doi.org/10.1111/j.1469-7610.2006.01687
Leckman JF (2003) Phenomenology of tics and natural history of tic disorders. Brain Dev 25(Suppl 1):S24–S28. https://doi.org/10.1016/s0387-7604(03)90004-0
Martino D, Cavanna AE, Robertson MM, Orth M (2012) Prevalence and phenomenology of eye tics in Gilles de la Tourette syndrome. J Neurol 259(10):2137–2140. https://doi.org/10.1007/s00415-012-6470-1
Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS (1998) Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102(1 Pt 1):14–19. https://doi.org/10.1542/peds.102.1.14
Ong MT, Mordekar SR, Seal A (2016) Fifteen-minute consultation: tics and Tourette syndrome. Arch Dis Child Educ Pract Ed 101(2):87–94. https://doi.org/10.1136/archdischild-2015-309138
Groth C, Mol Debes N, Rask CU, Lange T, Skov L (2017) Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry 56(4):304–312. https://doi.org/10.1016/j.jaac.2017.01.010
Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123(Pt 3):425–462. https://doi.org/10.1093/brain/123.3.425
Serajee FJ, MahbubulHuq AHM (2015) Advances in Tourette syndrome diagnoses and treatment. Pediatr Clin Nort Am 62(3):687–701. https://doi.org/10.1016/j.pcl,2015.03.007
Cavanna AE, Nani A (2013) Tourette syndrome and consciousness of action. Tremor Other Hyperkinet Mov (N Y). 3:tre-03-181-4368-1. https://doi.org/10.7916/D8PV6J33
Tagwerker Gloor F, Walitza S (2016) Tic disorders and Tourette syndrome: current concepts of etiology and treatment in children and adolescents. Neuropediatrics 47(2):84–96. https://doi.org/10.1055/s-0035-1570492
Darrow SM, Hirschtritt ME, Davis LK, Illmann C, Osiecki L, Grados M, Sandor P, Dion Y, King R, Pauls D, Budman CL, Cath DC, Greenberg E, Lyon GJ, Yu D, McGrath LM, McMahon WM, Lee PC, Delucchi KL, Scharf JM, Mathews CA (2017) Tourette Syndrome Association International Consortium for Genetics Identification of two heritable cross-disorder endophenotypes for Tourette syndrome. Am J Psychiatry 174(4):387–396. https://doi.org/10.1176/appi.ajp.2016.16020240
Ikemoto S (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56(1):27–78. https://doi.org/10.1016/j.brainresrev.2007.05.004
Scahill L, Erenberg G, Berlin CM Jr, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J (2006) Tourette Syndrome Association Medical Advisory Board: Practice Committee. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 3(2):192–206. https://doi.org/10.1016/j.nurx.2006.01.009
Kenney C, Hunter C, Jankovic J (2007) Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 22(2):193–197. https://doi.org/10.1002/mds.21222
Nikolaus S, Antke C, Müller HW (2009) In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behav Brain Res 204(1):32–66. https://doi.org/10.1016/j.bbr.2009.06.009
Hikosaka O, Sakamoto M, Usui S (1989) Functional properties of monkey caudate neurons. III. Activities related to expectation of target and reward. J Neurophysiol 61(4):814–32. https://doi.org/10.1152/jn.1989.61.4.814
Orduz D, Bischop DP, Schwaller B, Schiffmann SN, Gall D (2013) Parvalbumin tunes spike-timing and efferent short-term plasticity in striatal fast spiking interneurons. J Physiol 591(13):3215–3232. https://doi.org/10.1113/jphysiol.2012.250795
Gage GJ, Stoetzner CR, Wiltschko AB, Berke JD (2010) Selective activation of striatal fast-spiking interneurons during choice execution. Neuron 67(3):466–479. https://doi.org/10.1016/j.neuron.2010.06.034
Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18(12):527–535. https://doi.org/10.1016/0166-2236(95)98374-8 (Erratum.In:TrendsNeurosci1996Apr;19(4):143)
Centonze D, Grande C, Usiello A, Gubellini P, Erbs E, Martin AB, Pisani A, Tognazzi N, Bernardi G, Moratalla R, Borrelli E, Calabresi P (2003) Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci 23(15):6245–6254. https://doi.org/10.1523/JNEUROSCI.23-15-06245.2003
Wiltschko AB, Pettibone JR, Berke JD (2010) Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons. Neuropsychopharmacology 35(6):1261–1270. https://doi.org/10.1038/npp.2009.226
Horner KA, Westwood SC, Hanson GR, Keefe KA (2006) Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism. J Pharmacol Exp Ther 319(1):414–421
Centonze D, Bracci E, Pisani A, Gubellini P, Bernardi G, Calabresi P (2002) Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur J Neurosci 15(12):2049–2052. https://doi.org/10.1046/j.1460-9568.2002.02052.x
Dehorter N, Guigoni C, Lopez C, Hirsch J, Eusebio A, Ben-Ari Y, Hammond C (2009) Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons. J Neurosci 29(24):7776–7787. https://doi.org/10.1523/JNEUROSCI.1527-09.2009
Busceti CL, Bucci D, Molinaro G, Di Pietro P, Zangrandi L, Gradini R, Moratalla R, Battaglia G, Bruno V, Nicoletti F, Fornai F (2012) Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons. PLoS ONE 7(9):e44025. https://doi.org/10.1371/journal.pone.0044025
Lee K, Holley SM, Shobe JL, Chong NC, Cepeda C, Levine MS, Masmanidis SC (2017) Parvalbumin interneurons modulate striatal output and enhance performance during associative learning. Neuron 93(6):1451-1463.e4. https://doi.org/10.1016/j.neuron.2017.02.033
Zhou FM, Wilson C, Dani JA (2003) Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9(1):23–36. https://doi.org/10.1177/1073858402239588
Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci 23(3):120–126. https://doi.org/10.1016/s0166-2236(99)01501-5
Morris G, Arkadir D, Nevet A, Vaadia E, Bergman H (2004) Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43(1):133–143. https://doi.org/10.1016/j.neuron.2004.06.012
Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ (2012) Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75(1):58–64. https://doi.org/10.1016/j.neuron.2012.04.038
Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz ML, Leckman JF, Vaccarino FM (2005) Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 102(37):13307–13312. https://doi.org/10.1073/pnas.0502624102
Kataoka Y, Kalanithi PS, Grantz H, Schwartz ML, Saper C, Leckman JF, Vaccarino FM (2010) Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 518(3):277–291. https://doi.org/10.1002/cne.22206
Bloch MH, Leckman JF, Zhu H, Peterson BS (2005) Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 65(8):1253–1258. https://doi.org/10.1212/01.wnl.0000180957.98702.69
Sowell ER, Kan E, Yoshii J, Thompson PM, Bansal R, Xu D, Toga AW, Peterson BS (2008) Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 11(6):637–639. https://doi.org/10.1038/nn.2121
Hampson M, Tokoglu F, King RA, Constable RT, Leckman JF (2009) Brain areas coactivating with motor cortex during chronic motor tics and intentional movements. Biol Psychiatry 65(7):594–599. https://doi.org/10.1016/j.biopsych.2008.11.012
Stern E, Silbersweig DA, Chee KY, Holmes A, Robertson MM, Trimble M, Frith CD, Frackowiak RS, Dolan RJ (2000) A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 57(8):741–748. https://doi.org/10.1001/archpsyc.57.8.741
Church JA, Fair DA, Dosenbach NU, Cohen AL, Miezin FM, Petersen SE, Schlaggar BL (2009) Control networks in paediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain 132(Pt 1):225–238. https://doi.org/10.1093/brain/awn223
Ackermans L, Duits A, van der Linden C, Tijssen M, Schruers K, Temel Y, Kleijer M, Nederveen P, Bruggeman R, Tromp S, van Kranen-Mastenbroek V, Kingma H, Cath D, Visser-Vandewalle V (2011) Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain 134(Pt 3):832–844. https://doi.org/10.1093/brain/awq380
Kefalopoulou Z, Zrinzo L, Jahanshahi M, Candelario J, Milabo C, Beigi M, Akram H, Hyam J, Clayton J, Kass-Iliyya L, Silverdale M, Evans J, Limousin P, Hariz M, Joyce E, Foltynie T (2015) Bilateral globus pallidus stimulation for severe Tourette’s syndrome: a double-blind, randomised crossover trial. Lancet Neurol 14(6):595–605. https://doi.org/10.1016/S1474-4422(15)00008-3
Welter ML, Houeto JL, Worbe Y, Diallo MH, Hartmann A, Tezenas du Montcel S, Ansquer S, Thobois S, Fontaine D, Rouaud T, Cuny E, Karachi C, Mallet L, STIC study group (2019) Long-term effects of anterior pallidal deep brain stimulation for Tourette’s syndrome. Mov Disord 34(4):586–588. https://doi.org/10.1002/mds.27645
Johnson KA, Fletcher PT, Servello D, Bona A, Porta M, Ostrem JL, Bardinet E, Welter ML, Lozano AM, Baldermann JC, Kuhn J, Huys D, Foltynie T, Hariz M, Joyce EM, Zrinzo L, Kefalopoulou Z, Zhang JG, Meng FG, Zhang C, Ling Z, Xu X, Yu X, Smeets AY, Ackermans L, Visser-Vandewalle V, Mogilner AY, Pourfar MH, Almeida L, Gunduz A, Hu W, Foote KD, Okun MS, Butson CR (2019) Image-based analysis and long-term clinical outcomes of deep brain stimulation for Tourette syndrome: a multisite study. J Neurol Neurosurg Psychiatry 90(10):1078–1090. https://doi.org/10.1136/jnnp-2019-320379
Brito M, Teixeira MJ, Mendes MM, França C, Iglesio R, Barbosa ER, Cury RG (2019) Exploring the clinical outcomes after deep brain stimulation in Tourette syndrome. J Neurol Sci 402:48–51. https://doi.org/10.1016/j.jns.2019.05.011
Haense C, Müller-Vahl KR, Wilke F, Schrader C, Capelle HH, Geworski L, Bengel FM, Krauss JK, Berding G (2016) Effect of deep brain stimulation on regional cerebral blood flow in patients with medically refractory Tourette syndrome. Front Psychiatry 7:118. https://doi.org/10.3389/fpsyt.2016.00118
Jo HJ, McCairn KW, Gibson WS, Testini P, Zhao CZ, Gorny KR, Felmlee JP, Welker KM, Blaha CD, Klassen BT, Min HK, Lee KH (2018) Global network modulation during thalamic stimulation for Tourette syndrome. Neuroimage Clin 18:502–509. https://doi.org/10.1016/j.nicl.2018.02.018
Johnson KA, Duffley G, Anderson DN, Ostrem JL, Welter ML, Baldermann JC, Kuhn J, Huys D, Visser-Vandewalle V, Foltynie T, Zrinzo L, Hariz M, Leentjens AFG, Mogilner AY, Pourfar MH, Almeida L, Gunduz A, Foote KD, Okun MS, Butson CR (2020) Structural connectivity predicts clinical outcomes of deep brain stimulation for Tourette syndrome. Brain 143(8):2607–2623. https://doi.org/10.1093/brain/awaa188
Lerner A, Bagic A, Simmons JM, Mari Z, Bonne O, Xu B et al (2012) Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome. Brain 135:1926–1936. https://doi.org/10.1093/brain/aws104
Bostan AC, Dum RP, Strick PL (2010) The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci U S A 107:8452–8456. https://doi.org/10.1073/pnas.1000496107
Caligiore D, Mannella F, Arbib MA, Baldassarre G (2017) Dysfunctions of the basal ganglia-cerebellar-thalamo-cortical system produce motor tics in Tourette syndrome. PLoS Comput Biol 13(3):e1005395. https://doi.org/10.1371/journal.pcbi.1005395
Lennington JB, Coppola G, Kataoka-Sasaki Y, Fernandez TV, Palejev D, Li Y, Huttner A, Pletikos M, Sestan N, Leckman JF, Vaccarino FM (2016) Transcriptome analysis of the human striatum in Tourette syndrome. Biol Psychiatry 79(5):372–382. https://doi.org/10.1016/j.biopsych.2014.07.018
Murphy TK, Storch EA, Turner A, Reid JM, Tan J, Lewin AB (2010) Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder. J Neuroimmunol 229(1–2):243–7. https://doi.org/10.1016/j.jneuroim.2010.08.017
Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47(2):181–8. https://doi.org/10.1001/archpsyc.1990.01810140081011
Graham FK, Putnam LE, Leavitt LA (1975) Lead-stimulation effects of human cardiac orienting and blink reflexes. J Exp Psychol Hum Percept Perform 104(2):175–182
Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156(2–3):117–154. https://doi.org/10.1007/s002130100811
Swerdlow NR, Karban B, Ploum Y, Sharp R, Geyer MA, Eastvold A (2001) Tactile prepuff inhibition of startle in children with Tourette’s syndrome: in search of an “fMRI-friendly” startle paradigm. Biol Psychiatry 50(8):578–585. https://doi.org/10.1016/s0006-3223(01)01164-7
Perry W, Geyer MA, Braff DL (1999) Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry 56(3):277–281. https://doi.org/10.1001/archpsyc.56.3.277
Granholm E, Perry W, Filoteo JV, Braff D (1999) Hemispheric and attentional contributions to perceptual organization deficits on the global-local task in schizophrenia. Neuropsychology 13(2):271–281. https://doi.org/10.1037//0894-4105.13.2.271
Cadenhead KS, Geyer MA, Braff DL (1993) Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150(12):1862–1867. https://doi.org/10.1176/ajp.150.12.1862
Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122(1):35–43. https://doi.org/10.1007/BF02246439
Geyer MA, Wilkinson LS, Humby T, Robbins TW (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34(6):361–72. https://doi.org/10.1016/0006-3223(93)90180-l
Swerdlow NR, Eastvold A, Gerbranda T, Uyan KM, Hartman P, Doan Q, Auerbach P (2000) Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Psychopharmacology 151(4):368–378. https://doi.org/10.1007/s002130000490
Swerdlow NR, Caine SB, Braff DL, Geyer MA (1992) The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol 6(2):176–190. https://doi.org/10.1177/026988119200600210
Saint Marie RL, Miller EJ, Breier MR, Weber M, Swerdlow NR (2010) Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience 168(2):498–504. https://doi.org/10.1016/j.neuroscience.2010.03.037
Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E (1998) Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. J Psychopharmacol 12(3):239–245. https://doi.org/10.1177/026988119801200302
Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E (1999) Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. J Psychopharmacol 13(1):3–9. https://doi.org/10.1177/026988119901300101
Inui K, Urakawa T, Yamashiro K, Otsuru N, Nishihara M, Takeshima Y et al (2010) Non-linear laws of echoic memory and auditory change detection in humans. BMC Neurosci 11:80. https://doi.org/10.1186/1471-2202-11-80
Inui K, Takeuchi N, Sugiyama S, Motomura E, Nishihara M (2018) GABAergic mechanisms involved in the prepulse inhibition of auditory evoked cortical responses in humans. PLoS ONE 13(1):e0190481. https://doi.org/10.1371/journal.pone.0190481
Jahanshahi M, Rothwell JC (2017) Inhibitory dysfunction contributes to some of the motor and non-motor symptoms of movement disorders and psychiatric disorders. Philos Trans R Soc Lond B Biol Sci 372(1718):20160198. https://doi.org/10.1098/rstb.2016.0198
McBride J, Sumner P, Husain M (2018) Masked primes evoke partial responses. Q J Exp Psychol (Hove) 71(6):1431–1439. https://doi.org/10.1080/17470218.2017.1329326
Rawji V, Modi S, Latorre A, Rocchi L, Hockey L, Bhatia K, Joyce E, Rothwell JC, Jahanshahi M (2020) Impaired automatic but intact volitional inhibition in primary tic disorders. Brain 143(3):906–919. https://doi.org/10.1093/brain/awaa024
Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallett M (1996) Sensorimotor gating in boys with Tourette’s syndrome and ADHD: preliminary results. Biol Psychiatry 39(1):33–41. https://doi.org/10.1016/0006-3223(95)00101-8
Zebardast N, Crowley MJ, Bloch MH, Mayes LC, Wyk BV, Leckman JF, Pelphrey KA, Swain JE (2013) Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings. Psychiatry Res 214(1):33–41. https://doi.org/10.1016/j.pscychresns.2013.05.009
Kononowicz TW, Penney TB (2016) The contingent negative variation (CNV): timing isn’t everything. Curr Opin Behav Sci 8:231–237. https://doi.org/10.1016/j.cobeha.2016.02.022
Siniatchkin M, Kuppe A (2011) Neurophysiological determinants of tic severity in children with chronic motor tic disorder. Appl Psychophysiol Biofeedback 36(2):121–127. https://doi.org/10.1007/s10484-011-9155-0
Sutherland Owens AN, Miguel EC, Swerdlow NR (2011) Sensory gating scales and premonitory urges in Tourette syndrome. ScientificWorldJournal 11:736–741. https://doi.org/10.1100/tsw.2011.57
Belluscio BA, Jin L, Watters V, Lee TH, Hallett M (2011) Sensory sensitivity to external stimuli in Tourette syndrome patients. Mov Disord 26(14):2538–2543. https://doi.org/10.1002/mds.23977
Biermann-Ruben K, Miller A, Franzkowiak S, Finis J, Pollok B, Wach C, Südmeyer M, Jonas M, Thomalla G, Müller-Vahl K, Münchau A, Schnitzler A (2012) Increased sensory feedback in Tourette syndrome. Neuroimage 63(1):119–125. https://doi.org/10.1016/j.neuroimage.2012.06.059
Elle T, Alam M, Voigt C, Krauss JK, John N, Schwabe K (2020) Deep brain stimulation of the thalamic centromedian-parafascicular nucleus improves behavioural and neuronal traits in a rat model of Tourette. Behav Brain Res 378:112251. https://doi.org/10.1016/j.bbr.2019.112251
Schleyken S, Baldermann J, Huys D, Franklin J, Visser-Vandewalle V, Kuhn J, Kohl S (2020) Deep brain stimulation and sensorimotor gating in Tourette syndrome and obsessive-compulsive disorder. J Psychiatr Res 129:272–280. https://doi.org/10.1016/j.jpsychires.2020.07.016
Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, Chang S, Liu H, Dziura J, Walkup JT, Scahill L (2012) Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry 69(8):795–803. https://doi.org/10.1001/archgenpsychiatry.2011.1528
Kumari V, Premkumar P, Fannon D, Aasen I, Raghuvanshi S, Anilkumar AP, Antonova E, Peters ER, Kuipers E (2012) Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis. Schizophr Res 134(2–3):232–238. https://doi.org/10.1016/j.schres.2011.11.020
Swerdlow NR (2011) Are we studying and treating schizophrenia correctly? Schizophr Res 130(1–3):1–10. https://doi.org/10.1016/j.schres.2011.05.004
Muroni A, Paba S, Puligheddu M, Marrosu F, Bortolato M (2011) A preliminary study of finasteride in Tourette syndrome. Mov Disord 26(11):2146–2147. https://doi.org/10.1002/mds.23810
Devoto P, Frau R, Bini V, Pillolla G, Saba P, Flore G, Corona M, Marrosu F, Bortolato M (2012) Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation. Psychoneuroendocrinology 37(10):1630–1645. https://doi.org/10.1016/j.psyneuen.2011.09.018
Shu HJ, Eisenman LN, Jinadasa D, Covey DF, Zorumski CF, Mennerick S (2004) Slow actions of neuroactive steroids at GABAA receptors. J Neurosci 24(30):6667–6675. https://doi.org/10.1523/JNEUROSCI.1399-04.2004
Cadeddu R, Bäckström T, Floris G, Nordkild P, Segerdahl M, Bortolato M (2020) Isoallopregnanolone reduces tic-like behaviours in the D1CT-7 mouse model of Tourette syndrome. J Neuroendocrinol 32(1):e12754. https://doi.org/10.1111/jne.12754
Cadeddu R, Knutson DE, Mosher LJ, Loizou S, Odeh K, Fisher JL, Cook JM, Bortolato M (2021) The α6 GABAA receptor positive allosteric modulator DK-I-56-1 reduces tic-related behaviors in mouse models of Tourette syndrome. Biomolecules 11(2):175. https://doi.org/10.3390/biom11020175
Isaacs D, Riordan H (2020) Sensory hypersensitivity in Tourette syndrome: a review. Brain Dev 42(9):627–638. https://doi.org/10.1016/j.braindev.2020.06.003
Funding
Open access funding provided by Università degli Studi di Milano - Bicocca within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Schilke, E.D., Tremolizzo, L., Appollonio, I. et al. Tics: neurological disorders determined by a deficit in sensorimotor gating processes. Neurol Sci 43, 5839–5850 (2022). https://doi.org/10.1007/s10072-022-06235-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06235-0